日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Erratum to "Results of the first-in-human, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study of BIIB113 in healthy volunteers" [The Journal of Prevention of Alzheimer's Disease volume 12 (2025) 100302]

对“BIIB113 在健康志愿者中首次人体随机、双盲、安慰剂对照、单次和多次递增剂量研究的结果”的勘误 [阿尔茨海默病预防杂志第 12 卷(2025 年)100302]

Nery, Flavia C; Kaliszczak, Maciej; Suttle, Ben; Jones, Lori; Wu, Shuang; Xie, Jing; Curiale, Gioacchino; Yesilalan, Esin; Hirschhorn, Beth; Wilkes, Denisa; Singh, Dave; Bolin, Martin; Nag, Sangram; Varrone, Andrea; Stenkrona, Per; Morén, Anton Forsberg; Halldin, Christer; Yachnin, Jeffrey; Arnold, H Moore; Bullain, Szofia; Landen, Jaren; Gallagher, Diana; Hering, Heike

One-shot design of functional protein binders with BindCraft

利用 BindCraft 一次性设计功能性蛋白质结合剂

Martin Pacesa # ,Lennart Nickel # ,Christian Schellhaas # ,Joseph Schmidt ,Ekaterina Pyatova ,Lucas Kissling ,Patrick Barendse ,Jagrity Choudhury ,Srajan Kapoor ,Ana Alcaraz-Serna ,Yehlin Cho ,Kourosh H Ghamary ,Laura Vinué ,Brahm J Yachnin ,Andrew M Wollacott ,Stephen Buckley ,Adrie H Westphal ,Simon Lindhoud ,Sandrine Georgeon ,Casper A Goverde ,Georgios N Hatzopoulos ,Pierre Gönczy ,Yannick D Muller ,Gerald Schwank ,Daan C Swarts ,Alex J Vecchio ,Bernard L Schneider ,Sergey Ovchinnikov ,Bruno E Correia

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial

Autogene cevumeran联合或不联合atezolizumab治疗晚期实体瘤:一项I期试验

Lopez, Juanita; Powles, Thomas; Braiteh, Fadi; Siu, Lillian L; LoRusso, Patricia; Friedman, Claire F; Balmanoukian, Ani S; Gordon, Michael; Yachnin, Jeffrey; Rottey, Sylvie; Karydis, Ioannis; Fisher, George A; Schmidt, Marcus; Schuler, Martin; Sullivan, Ryan J; Burris, Howard A; Galvao, Vladimir; Henick, Brian S; Dirix, Luc; Jaeger, Dirk; Ott, Patrick A; Wong, Kit Man; Jerusalem, Guy; Schiza, Aglaia; Fong, Lawrence; Steeghs, Neeltje; Leidner, Rom S; Rittmeyer, Achim; Laurie, Scott A; Gort, Eelke; Aljumaily, Raid; Melero, Ignacio; Sabado, Rachel L; Rhee, Ina; Mancuso, Michael R; Muller, Lars; Fine, Gregg D; Yadav, Mahesh; Kim, Leesun; Leveque, Vincent J P; Robert, Alberto; Darwish, Martine; Qi, Ting; Zhu, Jiawen; Zhang, Jingbin; Twomey, Patrick; Rao, Gautham K; Low, Donald W; Petry, Chris; Lo, Amy A; Schartner, Jill M; Delamarre, Lélia; Mellman, Ira; Löwer, Martin; Müller, Felicitas; Derhovanessian, Evelyna; Cortini, Andrea; Manning, Luisa; Maurus, Daniel; Brachtendorf, Sebastian; Lörks, Verena; Omokoko, Tana; Godehardt, Eva; Becker, Dirk; Hawner, Christine; Wallrapp, Christine; Albrecht, Christian; Kröner, Christoph; Tadmor, Arbel D; Diekmann, Jan; Vormehr, Mathias; Jork, Anette; Paruzynski, Anna; Lang, Maren; Blake, Jonathon; Hennig, Oliver; Kuhn, Andreas N; Sahin, Ugur; Türeci, Özlem; Camidge, D Ross

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors

TIMEPOINT 是一项将 MTL-CEBPA 与帕博利珠单抗联合使用的 1 期研究,该研究支持 MTL-CEBPA 在实体瘤中的免疫调节作用。

Ruth Plummer ,Mikael H Sodergren ,Rose Hodgson ,Bríd M Ryan ,Nina Raulf ,Joanna P Nicholls ,Vikash Reebye ,Jon Voutila ,Laura Sinigaglia ,Tim Meyer ,David J Pinato ,Debashis Sarker ,Bristi Basu ,Sarah Blagden ,Natalie Cook ,Thomas R Jeffrey Evans ,Jeffrey Yachnin ,Cheng E Chee ,Daneng Li ,Anthony El-Khoueiry ,Maria Diab ,Kai-Wen Huang ,Madhava Pai ,Duncan Spalding ,Thomas Talbot ,Marcus S Noel ,Bridget Keenan ,Devalingam Mahalingam ,Min-Sun Song ,Mélanie Grosso ,Denis Arnaud ,Aurelie Auguste ,Dimitris Zacharoulis ,Jan Storkholm ,Iain McNeish ,Robert Habib ,John J Rossi ,Nagy A Habib

First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies

首次人体试验、多中心、开放标签的 I 期研究,评估 ATOR-1017(evunzekibart,一种 4-1BB 抗体)在晚期实体恶性肿瘤患者中的疗效

Carneiro, Ana; Hahn, Amanda; Ellmark, Peter; Enell Smith, Karin; Schultz, Lena; Ambarkhane, Sumeet; Yachnin, Jeffrey; Ullenhag, Gustav J

Enhancing the Adhesion Strength of Polymer-Based Joints via Atomic Layer Deposition Surface Modifications

通过原子层沉积表面改性增强聚合物基接头的粘合强度

Keren, Shachar; Yachnin, Elina; Cohen, Noy; Segal-Peretz, Tamar

Results of the first-in-human, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study of BIIB113 in healthy volunteers

首次在健康志愿者中进行的 BIIB113 人体随机、双盲、安慰剂对照、单次和多次递增剂量研究结果

Nery, Flavia C; Kaliszczak, Maciej; Suttle, Ben; Jones, Lori; Wu, Shuang; Xie, Jing; Curiale, Gioacchino; Yesilalan, Esin; Hirschhorn, Beth; Wilkes, Denisa; Singh, Dave; Bolin, Martin; Nag, Sangram; Varrone, Andrea; Stenkrona, Per; Morén, Anton Forsberg; Halldin, Christer; Yachnin, Jeffrey; Arnold, H Moore; Bullain, Szofia; Landen, Jaren; Gallagher, Diana; Hering, Heike

Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer

抗IL1RAP抗体Nadunolimab(CAN04)联合吉西他滨和白蛋白紫杉醇治疗晚期/转移性胰腺癌患者的疗效和安全性

Van Cutsem, Eric; Collignon, Joelle; Eefsen, Rikke L; Ochsenreither, Sebastian; Zvirbule, Zanete; Ivanauskas, Audrius; Arnold, Dirk; Baltruskeviciene, Edita; Pfeiffer, Per; Yachnin, Jeffrey; Magnusson, Susanne; Rydberg Millrud, Camilla; Sanfridson, Annika; Losic, Nedjad; Garcia-Ribas, Ignacio; Tersago, Dominique; Awada, Ahmad

Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial

ERBB2阳性乳腺癌辅助曲妥珠单抗治疗9周或1年的长期疗效:SOLD随机临床试验的二次分析

Joensuu, Heikki; Fraser, Judith; Wildiers, Hans; Huovinen, Riikka; Auvinen, Päivi; Utriainen, Meri; Villman, Kenneth K; Halonen, Päivi; Granstam-Björneklett, Helena; Tanner, Minna; Sailas, Liisa; Turpeenniemi-Hujanen, Taina; Yachnin, Jeffrey; Huttunen, Teppo; Neven, Patrick; Canney, Peter; Harvey, Vernon J; Kellokumpu-Lehtinen, Pirkko-Liisa; Lindman, Henrik

Consistency of a clinical decision support system with molecular tumour board recommendations for tumour sequencing-guided treatment of pancreatic cancer

临床决策支持系统与分子肿瘤委员会关于胰腺癌肿瘤测序指导治疗建议的一致性

Kordes, M; Malgerud, L; Frödin, J-E; Yachnin, J; Fernandez Moro, C; Ghazi, S; Pozzi Mucelli, R; Kartalis, N; Ghorbani, P; Del Chiaro, M; Wirta, V; Björnstedt, M; Liljefors, M G; Löhr, J-M